We also treated ZMYND8‐overexpressed MM cells with concentration gradients of CFZ and found that overexpression of ZMYND8 helped to reduce the administered amount of CFZ (Figure S9H, Supporting Information), which implies that upregulating ZMYND8 may favor the dose reduction of CFZ in patients with MM. The gene discussed is ZMYND8; the disease is Miyoshi myopathy.